Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.32

-1.1%

Dec 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2467)	1/21/2009 11:50:29 PM
From: Jibacoa	Read Replies (2) of 3722

ARIA was up 22.88% on volume of 628,833 about 1.2x its ADV On Jan13 it announced that it expects to end 2008 with approximately $39M in cash, or approximately $51M including a $12.5M milestone payment MRK related to the PII of deforolimus in patients with advanced prostatic Ca that began in the 4thQ It expects to report cash used of approximately $51M, or approximately $38.5M when including the prostate Ca milestone. It expects to report a net loss of approximately $74M. For 2009 it estimates its cash used in operations of $24M to $28M, reflecting an expected increase in milestone payments from MRK of approximately $37M based on the expected initiation of certain PII and PIII trials of deforolimus. But it still estimates a net loss of approximately $78M to $82M <g> The stock is just getting off its near term DT coming from its Aug15 H at $$3.55 Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next